• Served as a key strategic thought partner for C-suite and scientific leadership, reporting directly to the CBO• Drove business development activities across all stages, covering clinical, preclinical, and research collaborations, with experience across multiple therapeutic areas (inflammation and oncology)• Took point on deal strategy, sourcing, structuring, negotiating, implementing, and managing strategic alliances (in-licensing and out-licensing)• Co-led development of indication expansion strategy for Celsius’ lead program • Alliance-managed two pharma research collaborations totaling >$700M in potential milestones• Interfaced extensively with existing and potential partners, at conferences and executive-level meetings• Coordinated legal review of and negotiate key IP filings, CRO/CDMO contracts, CDAs, and more

• Collaborated with clients spanning seed-stage biotechs, top-10 pharmas, angel investors, and PE funds to structure/deliver projects for C-suites, franchise leads, investment committees, and scientific teams• Concurrently led 2 – 4 teams, each with 2 – 6 consultants, and served as a long-term career coach • Deconstructed nebulous client questions into actionable project plans then led team execution• Built ongoing relationships with clients across business development, area/portfolio strategy, and more• Specialized in innovative therapeutic approaches, including cell/gene therapies and protein degraders• Spearheaded development of customized, dynamic commercial opportunity forecast models, including franchise-level, risk-adjusted NPV models and underlying assumptions • Synthesized data from pipeline analyses, competitive intelligence, reports, filings, and interviews

• Staffed, trained, and managed more than 200 student consultants across more than 30 projects• Served on the board of directors, increasing membership by >20%